Dr. Jeffrey Harbold Jr., DO

Dr. Harbold practices at U.S. Dermatology Partners Tyler on Dominion Plaza in Tyler, Texas.

Dr. Harbold's NPI, 1700260197, was assigned on July 15, 2015. Dr. Harbold graduated from Kansas City University of Medicine and Biosciences College of Osteopathic Medicine in 2015. Dr. Harbold holds Texas license R2868.

Dr. Harbold's primary practice is U.S. Dermatology Partners Tyler on Dominion Plaza, at 1367 Dominion Plz, Tyler, TX 75703. The practice phone is (903) 534-6200.

Dr. Harbold's primary practice is U.S. Dermatology Partners Tyler on Dominion Plaza in Tyler, Texas. The medical group on file is U.S. Dermatology Partners. Dmand AI also links Dr. Harbold to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Harbold practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Harbold's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Harbold is board certified in dermatology by the American Board of Dermatology. Dr. Harbold is licensed in Texas.

Dmand AI lists acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, facial skin infection, itchy rashes, joint cyst and minor injury on trunk among the conditions Dr. Harbold treats.

CMS data shows 10,084 Medicare services from Dr. Harbold across 32 procedure codes in 2024, for 1,329 Medicare patients. Medicare paid $400,194 for them. Every service was in an office.

CMS counts 1,329 Medicare patients who saw Dr. Harbold in 2024. The largest group is 65 to 74, with 597 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.08, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Harbold's median patient age at 73, with 39% women.

In 2024, Dr. Harbold wrote 1,826 Medicare Part D claims for 840 patients. 97% of them were for generic drugs. CMS names the drug for 1,699 of them, across 20 drugs with 11 or more claims each, at $492,487 in total drug cost. In 2023, CMS named 968 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Harbold for performance year 2024, reported individually. Dr. Harbold accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 2,592 procedures of removal of skin lesions by Dr. Harbold, more than 99% of the clinicians it reports for that procedure.

CMS Open Payments shows 272 general payments to Dr. Harbold from 20 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 96% of the total. Abbvie Inc. paid the most, $1,340.

Dr. Harbold graduated from Kansas City University of Medicine and Biosciences College of Osteopathic Medicine in 2015.

Dr. Harbold is in network with 23 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.